Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Head and Neck Cancer

  Free Subscription


25.06.2018

3 Anticancer Res
1 Br J Oral Maxillofac Surg
2 Cancer Res
1 Clin Cancer Res
3 Clin Nucl Med
4 Dis Esophagus
1 Head Neck
1 Hum Pathol
6 Oral Oncol
1 PLoS One
1 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Res

  1. UESAWA Y, Sakagami H, Shi H, Hirose M, et al
    Quantitative Structure-Cytotoxicity Relationship of Furo[2,3-b]chromones.
    Anticancer Res. 2018;38:3283-3290.
    PubMed     Text format     Abstract available

  2. BOLM L, Kasmann L, Paysen A, Karapetis C, et al
    Multimodal Anti-tumor Approaches Combined with Immunotherapy to Overcome Tumor Resistance in Esophageal and Gastric Cancer.
    Anticancer Res. 2018;38:3231-3242.
    PubMed     Text format     Abstract available

  3. GANESH D, Sreenivasan P, Ohman J, Wallstrom M, et al
    Potentially Malignant Oral Disorders and Cancer Transformation.
    Anticancer Res. 2018;38:3223-3229.
    PubMed     Text format     Abstract available


    Br J Oral Maxillofac Surg

  4. ALLEN S, Harris R, Brown SL, Humphris G, et al
    High levels of socioeconomic deprivation do not inhibit patients' communication of concerns in head and neck cancer review clinics.
    Br J Oral Maxillofac Surg. 2018 Jun 13. pii: S0266-4356(18)30174.
    PubMed     Text format     Abstract available


    Cancer Res

  5. ZHANG J, Chen T, Yang X, Cheng H, et al
    Attenuated TRAF3 fosters alternative activation of NF-kappaB and reduced expression of anti-viral interferon, TP53, and RB to promote HPV-positive head and neck cancers.
    Cancer Res. 2018 Jun 19. pii: 0008-5472.CAN-17-0642.
    PubMed     Text format     Abstract available

  6. BROUWER AF, Eisenberg MC, Meza R
    Case Studies of Gastric, Lung, and Oral Cancer Connect Etiologic Agent Prevalence to Cancer Incidence.
    Cancer Res. 2018;78:3386-3396.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  7. KOTIAN S, Zhang L, Boufraqech M, Gaskins K, et al
    Dual Inhibition of HDAC and tyrosine kinase signaling pathways with CUDC-907 inhibits thyroid cancer growth and metastases.
    Clin Cancer Res. 2017 Jun 9. pii: clincanres.1043.2017.
    PubMed     Text format     Abstract available


    Clin Nucl Med

  8. SASIKUMAR A, Joy A, Pillai MRA, Oommen KE, et al
    Rare Case of Intratracheal Metastasis Detected on 68Ga-Prostate-Specific Membrane Antigen PET/CT Scan in a Case of Thyroglobulin Elevated Negative Iodine Scan Syndrome.
    Clin Nucl Med. 2018 Feb 9. doi: 10.1097/RLU.0000000000001992.
    PubMed     Text format     Abstract available

  9. SHARMA P, Shahid T, Mukherjee M
    Back Pain in a Patient With Parotid Carcinoma: Serendipitous Discovery of Acute Pancreatitis as the Cause on 18F-FDG PET/CT.
    Clin Nucl Med. 2018 Jan 19. doi: 10.1097/RLU.0000000000001976.
    PubMed     Text format     Abstract available

  10. SAMNICK S, Al-Momani E, Schmid JS, Mottok A, et al
    Initial Clinical Investigation of [18F]Tetrafluoroborate PET/CT in Comparison to [124I]Iodine PET/CT for Imaging Thyroid Cancer.
    Clin Nucl Med. 2018 Jan 19. doi: 10.1097/RLU.0000000000001977.
    PubMed     Text format     Abstract available


    Dis Esophagus

  11. SUN S, Chen P, Meng L, Li L, et al
    High preoperative plasma fibrinogen and serum albumin score is associated with poor survival in operable esophageal squamous cell carcinoma.
    Dis Esophagus. 2018 Jun 14. pii: 5037792. doi: 10.1093.
    PubMed     Text format     Abstract available

  12. DOHERTY MK, Leung Y, Su J, Naik H, et al
    Health utility scores from EQ-5D and health-related quality of life in patients with esophageal cancer: a real-world cross-sectional study.
    Dis Esophagus. 2018 Jun 14. pii: 5037798. doi: 10.1093.
    PubMed     Text format     Abstract available

  13. MIZUMOTO T, Hiyama T, Oka S, Yorita N, et al
    Diagnosis of superficial esophageal squamous cell carcinoma invasion depth before endoscopic submucosal dissection.
    Dis Esophagus. 2018;31.
    PubMed     Text format    

  14. KROESE TE, Goense L, van Hillegersberg R, de Keizer B, et al
    Detection of distant interval metastases after neoadjuvant therapy for esophageal cancer with 18F-FDG PET(/CT): a systematic review and meta-analysis.
    Dis Esophagus. 2018 Jun 16. pii: 5039611. doi: 10.1093.
    PubMed     Text format     Abstract available


    Head Neck

  15. OOFT ML, van Ipenburg J, van de Loo RJM, de Jong R, et al
    Differences in cancer gene copy number alterations between Epstein-Barr virus-positive and Epstein-Barr virus-negative nasopharyngeal carcinoma.
    Head Neck. 2018 Jun 21. doi: 10.1002/hed.25195.
    PubMed     Text format     Abstract available


    Hum Pathol

  16. LIU Z, Ma C, Ma G, Sun X, et al
    High expression of tumor necrosis factor receptor 2 in tissue is associated with progression and prognosis of esophageal squamous cell carcinoma.
    Hum Pathol. 2018 Jun 16. pii: S0046-8177(18)30214.
    PubMed     Text format     Abstract available


    Oral Oncol

  17. PENG YL, Chen L, Shen GZ, Li YN, et al
    Interobserver variations in the delineation of target volumes and organs at risk and their impact on dose distribution in intensity-modulated radiation therapy for nasopharyngeal carcinoma.
    Oral Oncol. 2018;82:1-7.
    PubMed     Text format     Abstract available

  18. MASSA ST, Rohde RL, Mckinstry C, Gresham M, et al
    An assessment of patient burdens from head and neck cancer survivorship care.
    Oral Oncol. 2018;82:115-121.
    PubMed     Text format     Abstract available

  19. SIANO M, Espeli V, Mach N, Bossi P, et al
    Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial.
    Oral Oncol. 2018;82:144-151.
    PubMed     Text format     Abstract available

  20. HOROWITZ G, Hosni A, Yu E, Xu W, et al
    Prevalence, prognosis, and treatment implications of retropharyngeal nodes in unknown primary head and neck carcinoma.
    Oral Oncol. 2018;82:162-167.
    PubMed     Text format     Abstract available

  21. RETTIG EM, Bishop JA, Agrawal N, Chung CH, et al
    HEY1 is expressed independent of NOTCH1 and is associated with poor prognosis in head and neck squamous cell carcinoma.
    Oral Oncol. 2018;82:168-175.
    PubMed     Text format     Abstract available

  22. FERRAROTTO R, William WN Jr, Tseng JE, Marur S, et al
    Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinoma.
    Oral Oncol. 2018;82:83-90.
    PubMed     Text format     Abstract available


    PLoS One

  23. SANTOS JD, Meira KC, Simoes TC, Guimaraes RM, et al
    Inequalities in esophageal cancer mortality in Brazil: Temporal trends and projections.
    PLoS One. 2018;13:e0193135.
    PubMed     Text format     Abstract available


    Thyroid

  24. TRAN BM, Roshan DJ, Abraham E, Wang LY, et al
    The Prognostic Impact of Tumor Size in Papillary Thyroid Carcinoma is Modified by Age.
    Thyroid. 2018 Jun 19. doi: 10.1089/thy.2017.0607.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: